An earlier study of a genetic mutation in some mesothelioma patients showed the change made people more susceptible to developing several types of cancer, but the patients also fared better when using platinum-based chemotherapy. Besides mesothelioma, patients with the BAP1 mutation were more likely to receive a diagnosis of basal cell carcinoma, renal carcinoma, cutaneous melanoma, and meningioma.
These patients experienced much longer survival times than those without the mutation undergoing the same chemotherapy regimen. For the cancer patient without the mutation, median survival time following platinum chemotherapy was just 2.4 years. For the cancer patient with the mutation, the median survival time nearly tripled to 7.9 years. However, the NCI senior investigator said that a higher than normal number of young and/or female patients in the study may have affected the median survival time for those with the mutation. The new clinical trial is a follow-up to this study.
In the new clinical trial, participants have the option of a remote or in-person setting for monitoring. Those opting for remote participation provide the researchers with annual medical and family histories. Those preferring the more closely monitored option will have annual blood tests, physical exams, and scans. Participants with the mutation can have family members as young as two years old join the study, and all blood relatives are invited to participate.
While not all mesothelioma patients possess the BAP1 mutation, it is wise for every patient to undergo genetic testing. Not only does such testing offer more information when making treatment decisions, but the patient’s relatives can make a decision regarding their own genetic testing if the mesothelioma patient is predisposed. Such knowledge can lead to regular screening so that mesothelioma or any of the other related cancers are detected at the earliest stages. If a relative has the BAP1 mutation, they can take extra care to avoid exposure to any type of toxin or carcinogen.
If you or a loved one received a mesothelioma diagnosis, you need the services of the experienced Philadelphia mesothelioma attorneys at Brookman, Rosenberg, Brown & Sandler at this difficult time. Call us today for a free consultation at 215-569-4000 or contact us online. Located in Philadelphia, we proudly represent clients throughout New Jersey and Pennsylvania, including Delaware County, Chester County, and Philadelphia County.
Brookman, Rosenberg, Brown & Sandler is honored to announce that Howell K. Rosenberg, Esq. and Laurence H. Brown, Esq. have…
Occupational hazards are associated with working at an oil refinery, from the risk of fires or explosions to being exposed…
The recurring pattern of poor communication plagues both the City of Atlantic City and the Atlantic City Public Schools system…
Asbestos shingle siding dates back to 1907, and the National Board of Fire Underwriters later endorsed it for its resistance…
Mesothelioma is an incurable disease that will have an immeasurable impact on both the person who was diagnosed and their…
Depending on the kind of mesothelioma you have and whether it has progressed, treatment options may alleviate symptoms and extend…